Spire Healthcare confirms 2017 guidance
FTSE 250 hospital group Spire Healthcare confirmed its previous guidance for 2017 on Tuesday.
FTSE 250
19,450.67
17:14 18/04/24
n/a
n/a
FTSE 350
4,334.00
17:14 18/04/24
n/a
n/a
FTSE All-Share
4,290.02
16:54 18/04/24
n/a
n/a
Health Care Equipment & Services
11,785.09
17:14 18/04/24
3.98%
451.45
Spire Healthcare Group
248.00p
16:50 18/04/24
3.98%
9.50p
The group, which is the second largest provider of private healthcare in the UK, continues to expect revenues of between £929m and £932m and underlying earnings before interest, tax, depreciation and amortisation of £149m to £151m. In addition, net debt at the end of December is expected to be around £465m.
Spire is due to announce its preliminary results for the full year on 2 March, with guidance for the 2018 full financial year also due to be given.
At 0805 GMT, the shares were down 1.7% to 242.35p.